Add time:08/16/2019         Source:sciencedirect.com

BackgroundHepatocellular carcinoma is the second deadliest cancer with limited treatment options. Loss of PTEN causes the P13K/Akt pathway to be hyperactive which contributes to cell survival and resistance to therapeutics in various cancers, including the liver cancer. Hence molecules targeting this pathway present good therapeutic strategies for liver cancer.

We also recommend Trading Suppliers and Manufacturers of Lanatosides (cas 11014-59-8). Pls Click Website Link as below: cas 11014-59-8 suppliers